SUMMARY Pre-embedding immunocytochemistry for the active form of glutamate decarboxylase (GAD 67 ) and postembedding staining for â„-aminobutyric acid (GABA) were compared as markers for central GABAergic terminals in the phrenic motor nucleus, in which phrenic motor neurons had been retrogradely labeled with cholera toxin B-horseradish peroxidase. Nerve terminals with or without GAD 67 immunoreactivity were identified in one ultrathin section. GABA was localized with immunogold in an adjacent section after etching and bleaching. GABA labeling density was assessed over 519 GAD 67 -positive and GAD 67 -negative nerve terminals in the phrenic motor nucleus. Frequency histograms showed that statistically higher densities of gold particles occurred over most GAD 67 -positive terminals. However, some GAD 67 -negative terminals also showed high densities of gold particles, and some GAD 67 -positive terminals showed low densities. Preabsorption of the anti-GABA antibody with a GABA-protein conjugate, but not with other amino acid-protein conjugates, significantly reduced gold labeling over both GAD 67 -positive and GAD 67 -negative terminals. These results show that the presence of GAD 67 immunoreactivity correlates strongly with high densities of immunogold labeling for GABA in nerve terminals in the phrenic motor nucleus. Preabsorption controls indicate that authentic GABA was localized in the postembedding labeling procedure. Only a small proportion of intensely GABAimmunoreactive terminals lack GAD 67 , suggesting that both GAD 67 and GABA are reliable markers of GABAergic nerve terminals. (J Histochem Cytochem 46:1261-1268, 1998) GABAergic nerve terminals throughout the central nervous system have been identified using either preor postembedding immunogold methods to localize â„-aminobutyric acid (GABA), or pre-embedding immunocytochemistry to visualize glutamate decarboxylase (GAD), the enzyme required for synthesis of GABA from l-glutamate (McLaughlin et al. 1975;Gabbott et al. 1986;Babb et al. 1988;Zhan et al. 1989; Helfert et al. 1992;Tai and Goshgarian 1996). A general presumption is that all nerve terminals containing GAD 67 , the active form of the enzyme, contain high levels of GABA, but this relationship has not been analyzed quantitatively. Maxwell et al. (1989) showed that, in the lateral cervical nucleus of the cat, GAD-immunoreactive terminals exhibited high densities of gold labeling for GABA but did not show quantitatively whether the density of GABA labeling was high over all GAD-positive terminals and low over all GAD-negative terminals. We have previously used tissue fixed with 2.5% glutaraldehyde to localize GAD 67 immunoreactivity and showed that it was suitable for immunogold localization of the amino acid neurotransmitter glutamate (Murphy et al. 1996).Using similarly processed tissue in this study, we determined whether GAD 67 -containing nerve terminals labeled by pre-embedding immunocytochemistry showed high densities of gold particles after postembedding im-